CORT
Corcept Therapeutics Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Corcept Therapeutics Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Corcept Therapeutics Inc
81.20
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $1.1B | 14.72% | +2.31% | |
| 2 | Ingalls & SnyderIngalls & Snyder | $691.0M | 9.41% | +4.40% | |
| 3 | Renaissance TechnologiesRenaissance Technologies | $457.5M | 6.23% | −7.41% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $438.6M | 5.97% | +4.65% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $362.8M | 4.94% | +2.34% | |
| 6 | Parallel AdvisorsParallel | $344.5M | 4.69% | −0.38% | |
| 7 | FMRFMR | $290.2M | 3.95% | +4.62% | |
| 8 | State StreetState Streetindex-like | $285.2M | 3.88% | +2.45% | |
| 9 | AQR Capital ManagementAQR | $224.6M | 3.06% | +535.78% | |
| 10 | Geode Capital ManagementGeodeindex-like | $220.2M | 3.00% | −6.68% | |
| 11 | First Trust AdvisorsFirst Trust | $159.1M | 2.17% | −15.82% | |
| 12 | Tang Capital ManagementTang | $130.4M | 1.78% | 0.00% | |
| 13 | UBS GroupUBS | $119.8M | 1.63% | +1.03% | |
| 14 | Dimensional Fund AdvisorsDimensional | $114.7M | 1.56% | −15.09% | |
| 15 | Charles Schwab Investment ManagementCharles Schwabindex-like | $100.7M | 1.37% | +3.36% | |
| 16 | Morgan StanleyMorgan Stanley | $98.9M | 1.35% | +11.65% | |
| 17 | D. E. ShawD. E. Shaw | $76.8M | 1.05% | −25.25% | |
| 18 | Cerity PartnersCerity Partners | $69.3M | 0.94% | +8.94% | |
| 19 | MPM Oncology Impact ManagementMPM Oncology Impact | $67.0M | 0.91% | −21.78% | |
| 20 | Northern TrustNorthern Trustindex-like | $65.5M | 0.89% | +17.20% | |
| 21 | Emerald AdvisersEmerald | $65.1M | 0.89% | +264.05% | |
| 22 | Fuller & Thaler Asset ManagementFuller & Thaler | $61.7M | 0.84% | new | |
| 23 | Jacobs Levy Equity ManagementJacobs Levy Equity | $60.5M | 0.82% | new | |
| 24 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $53.4M | 0.73% | +4.03% | |
| 25 | Two Sigma InvestmentsTwo Sigma | $53.0M | 0.72% | −35.50% |
431 managers report $7.3B of Corcept Therapeutics on form 13F for the quarter ended Jun 30 '26. 29 of them hold 80% of it; BlackRock is largest at 14.72%.
Expected move
Inputsspot 81.12exp Nov 20ATM strike 80ATM straddle 12.15IV 79%